Morphological changes in breast tissue with menstrual cycle

Modern Pathology

Volumn 15, Issue 12, 2002, Pages 1348-1356

  Ramakrishnan, Rathi ^a   Khan, Seema A ^a   Badve, Sunil ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Hospital   (United States)

Author keywords

Breast; Menstrual cycle classification; Menstrual morphology

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; AUTOPSY; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DATA BASE; EDEMA; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MITOSIS; MYOEPITHELIUM CELL; ORAL CONTRACEPTION; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

ADOLESCENT; ADULT; BREAST; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; MIDDLE AGED; TIME FACTORS;

EID: 0036901598     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000039566.20817.46     Document Type: Article

References (35)

1. Khan S, Sachdeva A, Naim S, Meguid M, Marx W, Simon H, et al. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Cancer Epidemiol Biomarkers Prey 1999;8:867-72.
2. Khan S, Rogers M, Khurana K, Meguid M, Numann P, Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998;90:37-42.
3. Ingle J. Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. Oncology (Huntingt) 2001;15:28-34.
4. Shibutani S, Ravindernath A, Terashima I, Suzuki N, Laxmi Y, Kanno Y, et al. Mechanism of lower genotoxicity of toremifene compared with tamoxifen. Cancer Res 2001;61:3925-31.
5. Fallowfield L, Fleissig A, Edwards R, West A, Powles T, Howell A, et al. Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 2001;19:1885-92.
6. Johannisson E, Landgren B, Rohr H, Diczfalusy E. Endometrial morphology and peripheral hormone levels in women with regular menstrual cycles. Fertil Steril 1987;48:401-8.
7. Lenton E, Landgren B, Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: Identification of the short luteal phase. Br J Obstet Gynaecol 1984;91:685-9.
8. Li T, Rogers A, Lenton E, Dockery P, Cooke I. A comparison between two methods of chronological dating of human endometrial biopsies during the luteal phase, and their correlation with histologic dating. Fertil Steril 1987;48:928-32.
9. Ferguson D. An ultrastructural study of mitosis and cytokinesis in normal "resting" human breast. Cell Tissue Res 1988;252:581-7.
10. Longacre T, Bartow S. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10:382-93.
11. Vogel P, Georgiade N, Fetter B, Vogel F, McCarty KJ. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981;104:23-34.
12. Rosenburg A. Ueber menstruelle dutch das corpus luteum bedingte mammaveranderungen. Frankf Z Pathol Munchen Wiesb 1922;27:466-506.
13. Friedman M, Finkler R, Antopol W. The relation of ovarian hormones to benign breast hyperplasia and neoplasia. Radiology 1939;33:725-36.
14. Haagensen C. Diseases of the Breast. 2nd Ed. Philadelphia: Saunders; 1971.
15. Taylor H. The relation of chronic mastitis to certain hormones of the ovary and the pituitary and to coincident gynaecological reasons. Surg Gynecol Obstet 1922;62:129-48.
16. Geschickter C. Diseases of the Breast: Diagnosis, Pathology, Treatment. 2nd Ed. Philadelphia: Lippincott; 1945.
17. Ferguson D, Anderson T. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 1981;44:177-81.
18. Going J, Anderson T, Battersby S, MacIntyre C. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1988;130:193-204.
19. Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997;176:123-8.
20. Foote F, Stewart F. Comparative studies of cancerous versus noncancerous breasts. Ann Surg 1945;121:197-222.
21. Anderson T, Ferguson D, Raab G. Cell turnover in the "resting" human breast: Influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982;46:376-82.
22. Anderson T, Howell A, King R. Comment on progesterone effects in breast tissue. Breast Cancer Res Treat 1987;10:65-6.
23. Potten C, Watson R, Williams G, Tickle S, Roberts S, Harris M, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988;58:163-70.
24. Simpson H, Cornelissen G, Katinas G, Halberg F. Metaanalysis of sequential luteal-cycle-associated changes in human breast tissue. Breast Cancer Res Treat 2000;63:171-3.
25. Speroff L. Role of progesterone in normal breast physiology. J Reprod Med 1999;44:172-9.
26. Meyer J. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 1977;8:67-81.
27. Key T, Pike M. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43.
28. Dulbecco R, Allen W, Bologna M, Bowman M. Marker evolution during the development of the rat mammary gland: Stem cells identified by markers and the role of myoepithelial cells. Cancer Res 1986;46:2449-56.
29. Badwe R, Gregory W, Chaudary M, Richards M, Bentley A, Rubens R, et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991;337:1261-4.
30. Badwe R, Mittra I, Havaldar R. Timing of surgery during the menstrual cycle and prognosis of breast cancer. J Biosci 2000;25:113-20.
31. Cooper L, Gillett C, Patel N, Bames D, Fentiman I. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor. Cancer Epidemiol Biomarkers Prev 1999;86:2053-8.
32. Donegan W, Shah D. Prognosis of patients with breast cancer related to the timing of operation. Arch Surg 1993;128:309-13.
33. Iatoi I. Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis. Breast Cancer Res Treat 1998;52:217-25.
34. Milella M, Nistico C, Perraresi V, Vaccaro A, Fabi A, D'Ottavio A, et al. Breast cancer and timing of surgery during menstrual cycle: A 5-year analysis of 248 premenopausal women. Breast Cancer Res Treat 1999;55:259-66.
35. Nomura Y, Kataoka A, Tsutsui S, Murakami S, Takenaka Y. Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer. Eur J Cancer 1999;35:1326-30.